Régis Bordet Selected Research

Thromboplastin (Tissue Factor)

1/2006	Activated protein C increases sensitivity to vasoconstriction in rabbit Escherichia coli endotoxin-induced shock.
9/2005	Pretreatment with peroxysome proliferator-activated receptor alpha agonist fenofibrate protects endothelium in rabbit Escherichia coli endotoxin-induced shock.
10/2003	Dietary lipid lowering modifies plaque phenotype in rabbit atheroma after angioplasty: a potential role of tissue factor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Régis Bordet Research Topics

Disease

44	Stroke (Strokes) 04/2024 - 05/2002
26	Alzheimer Disease (Alzheimer's Disease) 10/2023 - 01/2005
22	Cognitive Dysfunction 12/2023 - 09/2009
20	Alcoholism (Alcohol Abuse) 12/2019 - 02/2012
16	Ischemic Stroke 04/2024 - 05/2002
15	Dementia (Dementias) 01/2022 - 01/2003
15	Brain Ischemia (Cerebral Ischemia) 05/2018 - 01/2003
13	Parkinson Disease (Parkinson's Disease) 12/2022 - 11/2004
13	Ischemia 05/2014 - 04/2003
11	Infarction (Infarctions) 01/2021 - 04/2003
9	Inflammation (Inflammations) 10/2023 - 10/2005
7	Hypertension (High Blood Pressure) 04/2024 - 05/2002
6	Disease Progression 12/2022 - 12/2013
5	Cerebral Hemorrhage 01/2019 - 12/2003
5	Hemorrhage 01/2019 - 12/2003
4	Body Weight (Weight, Body) 12/2022 - 02/2008
4	Schizophrenia (Dementia Praecox) 03/2021 - 01/2008
4	Seizures (Absence Seizure) 01/2021 - 09/2012
4	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2019 - 10/2016
3	Transient Ischemic Attack 04/2024 - 11/2004
3	Weight Gain 01/2018 - 04/2011
3	Cerebral Infarction 11/2009 - 07/2003
3	Erectile Dysfunction 06/2009 - 03/2006
3	Brain Infarction 02/2009 - 01/2003
3	Atherosclerotic Plaque (Atheroma) 01/2007 - 10/2003
3	Shock 01/2006 - 08/2004
2	Atrial Fibrillation 04/2024 - 02/2013
2	Neutropenia 12/2022 - 04/2005
2	Nervous System Diseases (Neurological Disorders) 01/2022 - 09/2012
2	Hematoma 01/2022 - 01/2019
2	Glucose Intolerance 10/2019 - 01/2018
2	Binge-Eating Disorder (Binge Eating Disorder) 05/2019 - 09/2012
2	Psychotic Disorders (Schizoaffective Disorder) 05/2019 - 01/2014
2	Atrophy 01/2019 - 01/2019
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2018 - 02/2012
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 01/2014
2	Sleep Deprivation 01/2018 - 01/2017
2	Overweight 01/2018 - 04/2011
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 04/2017 - 01/2015
2	Drug-Related Side Effects and Adverse Reactions 01/2017 - 07/2014
2	Neoplasms (Cancer) 10/2016 - 01/2003
2	Brain Injuries (Brain Injury) 05/2016 - 06/2009

Drug/Important Bio-Agent (IBA)

29	Biomarkers (Surrogate Marker)IBA 10/2023 - 03/2005
22	Baclofen FDA LinkGeneric 12/2019 - 11/2010
12	Amyloid (Amyloid Fibrils)IBA 10/2023 - 03/2005
12	Neuroprotective AgentsIBA 06/2014 - 04/2003
11	LipidsIBA 10/2019 - 01/2003
11	Fenofibrate (CiL)FDA LinkGeneric 05/2016 - 07/2003
9	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 12/2003
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2024 - 05/2002
6	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2015 - 09/2003
5	Proteins (Proteins, Gene)FDA Link 10/2023 - 10/2005
5	PPAR alphaIBA 01/2015 - 07/2003
5	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 05/2010 - 11/2004
4	IronIBA 12/2022 - 07/2014
4	Antipsychotic Agents (Antipsychotics)IBA 03/2021 - 04/2011
4	CholesterolIBA 01/2021 - 05/2002
4	Atorvastatin (Lipitor)FDA Link 01/2021 - 03/2007
4	Memantine (Namenda)FDA Link 05/2020 - 05/2013
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2018 - 08/2004
4	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2018 - 01/2008
4	PotassiumIBA 01/2013 - 04/2003
4	LipopolysaccharidesIBA 01/2006 - 04/2003
3	AnticoagulantsIBA 04/2024 - 01/2019
3	Levodopa (L Dopa)FDA LinkGeneric 12/2022 - 05/2013
3	BenzodiazepinesIBA 12/2021 - 02/2014
3	Blood Proteins (Serum Proteins)IBA 01/2021 - 11/2019
3	Donepezil (Aricept)FDA LinkGeneric 05/2020 - 01/2017
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 11/2013
3	Peptides (Polypeptides)IBA 01/2019 - 09/2009
3	EnzymesIBA 01/2018 - 07/2003
3	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 06/2014 - 07/2009
3	EndotoxinsIBA 01/2006 - 08/2004
3	Thromboplastin (Tissue Factor)IBA 01/2006 - 10/2003
3	Escherichia coli endotoxinIBA 01/2006 - 08/2004
3	ApolipoproteinsIBA 09/2005 - 07/2003
2	Chelating AgentsIBA 12/2022 - 10/2016
2	DeferiproneIBA 12/2022 - 10/2018
2	Oxygen (Dioxygen)IBA 08/2022 - 02/2012
2	ORALIT (ORS)IBA 01/2022 - 01/2021
2	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 09/2009
2	A-factor (Streptomyces)IBA 10/2019 - 04/2015
2	HDL CholesterolIBA 01/2018 - 09/2012
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2016 - 01/2014
2	Simvastatin (Zocor)FDA LinkGeneric 05/2016 - 03/2007
2	Acetylcholine (Acetylcholine Chloride)FDA Link 10/2015 - 04/2005
2	Methylphenidate (Ritalin)FDA LinkGeneric 05/2015 - 07/2012
2	gamma-Aminobutyric Acid (GABA)IBA 07/2014 - 05/2014
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2014 - 01/2003
2	GABA-B ReceptorsIBA 05/2014 - 11/2010
2	Protein Disulfide-IsomerasesIBA 01/2014 - 06/2009
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2014 - 07/2007
2	oxidized low density lipoproteinIBA 09/2012 - 09/2005
2	Antidepressive Agents (Antidepressants)IBA 06/2011 - 02/2009
2	Adenosine Triphosphate (ATP)IBA 02/2011 - 11/2008

Therapy/Procedure

14	Therapeutics 04/2024 - 05/2002
8	Off-Label Use 04/2018 - 09/2012
5	Secondary Prevention 04/2024 - 02/2018
4	Thrombolytic Therapy 05/2018 - 03/2013
2	Activities of Daily Living (ADL) 12/2023 - 11/2018